Basal cell carcinoma of the skin of the breast is a type of skin cancer that arises from the basal cells in the epidermis. It is primarily caused by prolonged exposure to ultraviolet (UV) radiation from the sun or tanning beds. This condition is clinically significant as it can lead to local tissue destruction and, although rarely metastasizes, requires accurate diagnosis and treatment. The ICD-10 Code C44.511 facilitates precise documentation, billing, and public health reporting, ensuring that healthcare providers can effectively manage and track this condition.
ICD-10 Code C44.511 specifically identifies basal cell carcinoma of the skin located on the breast. This code is used when documenting cases of this skin cancer, which is characterized by abnormal growths of basal cells. It is essential for accurate clinical documentation and billing, particularly when distinguishing this condition from other skin cancers or complications.
Basal cell carcinoma of the skin of the breast is primarily caused by UV radiation exposure, leading to mutations in the DNA of skin cells. This cancer typically progresses slowly and may present as a non-healing sore, a shiny bump, or a scaly patch. Early detection and treatment are crucial to prevent local invasion and complications.
ICD-10 Code C44.511 is utilized in SOAP notes to document the patient's symptoms, assessment findings, and treatment plans related to basal cell carcinoma of the skin of the breast. This code is relevant in both acute and chronic care settings, ensuring comprehensive patient management.
In SOAP notes, ICD-10 Code C44.511 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of basal cell carcinoma of the skin of the breast. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.
Basal cell carcinoma of the skin of the breast requires prompt medical attention to prevent progression. Treatment options may include surgical excision, Mohs micrographic surgery, or topical chemotherapy, depending on the tumor's size and location.
HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code C44.511 is crucial for billing in hospital, ER, or outpatient settings, ensuring accurate claims for basal cell carcinoma treatment.
CPT Code | Description |
---|---|
11600 | Excision, malignant skin lesion, face, ears, scalp, neck; excised diameter excised 0.5 cm or less |
17311 | Destruction of malignant skin lesions; first lesion |
11100 | Biopsy of skin, excisional, for lesions requiring pathology examination |
Common Questions About Using ICD-10 Code C44.511 for Basal cell carcinoma of skin of breast
What are the common symptoms of basal cell carcinoma of the breast?
Common symptoms include a non-healing sore, shiny bump, or scaly patch on the breast. Patients may also report changes in the appearance of the skin in the affected area.
How is basal cell carcinoma of the breast treated?
Treatment typically involves surgical excision, Mohs micrographic surgery, or topical chemotherapy, depending on the size and location of the tumor.
Is basal cell carcinoma of the breast contagious?
No, basal cell carcinoma is not contagious. It is caused by genetic factors and environmental exposures, particularly UV radiation.
How often should patients with basal cell carcinoma be monitored?
Patients should have regular follow-up appointments, typically every 6 to 12 months, to monitor for recurrence and manage any new skin changes.
Clinical Notes
SOAP notes
DAP notes
AI medical notes